TP53 and neoplasm: In some cases, DDX3X has been shown to act as an oncosuppressor by enhancing the p53-p21 axis; however, in tumors with non-functional p53, DDX3X has anti-apoptotic activity, promoting tumor growth by reducing caspase 3 activation [14].